BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 7478612)

  • 1. Highly-expressed p100/p52 (NFKB2) sequesters other NF-kappa B-related proteins in the cytoplasm of human breast cancer cells.
    Dejardin E; Bonizzi G; Bellahcène A; Castronovo V; Merville MP; Bours V
    Oncogene; 1995 Nov; 11(9):1835-41. PubMed ID: 7478612
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Selective activation of NF-kappa B subunits in human breast cancer: potential roles for NF-kappa B2/p52 and for Bcl-3.
    Cogswell PC; Guttridge DC; Funkhouser WK; Baldwin AS
    Oncogene; 2000 Feb; 19(9):1123-31. PubMed ID: 10713699
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Immunohistochemical analysis of NF-kappaB signaling proteins IKKepsilon, p50/p105, p52/p100 and RelA in prostate cancers.
    Seo SI; Song SY; Kang MR; Kim MS; Oh JE; Kim YR; Lee JY; Yoo NJ; Lee SH
    APMIS; 2009 Aug; 117(8):623-8. PubMed ID: 19664134
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mechanism of expression and role in transcriptional control of the proto-oncogene NFKB-2/LYT-10.
    Chang CC; Zhang J; Lombardi L; Neri A; Dalla-Favera R
    Oncogene; 1994 Mar; 9(3):923-33. PubMed ID: 8108136
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Overproduction of NFKB2 (lyt-10) and c-Rel: a mechanism for HTLV-I Tax-mediated trans-activation via the NF-kappa B signalling pathway.
    Lanoix J; Lacoste J; Pepin N; Rice N; Hiscott J
    Oncogene; 1994 Mar; 9(3):841-52. PubMed ID: 8108127
    [TBL] [Abstract][Full Text] [Related]  

  • 6. NF-kappa B precursor p100 inhibits nuclear translocation and DNA binding of NF-kappa B/rel-factors.
    Naumann M; Nieters A; Hatada EN; Scheidereit C
    Oncogene; 1993 Aug; 8(8):2275-81. PubMed ID: 8336950
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Activation of multiple NF-kappa B/Rel DNA-binding complexes by tumor necrosis factor.
    Beg AA; Baldwin AS
    Oncogene; 1994 May; 9(5):1487-92. PubMed ID: 8152812
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The generation of nfkb2 p52: mechanism and efficiency.
    Heusch M; Lin L; Geleziunas R; Greene WC
    Oncogene; 1999 Nov; 18(46):6201-8. PubMed ID: 10597218
    [TBL] [Abstract][Full Text] [Related]  

  • 9. High levels of p105 (NFKB1) and p100 (NFKB2) proteins in HPV16-transformed keratinocytes: role of E6 and E7 oncoproteins.
    Havard L; Rahmouni S; Boniver J; Delvenne P
    Virology; 2005 Jan; 331(2):357-66. PubMed ID: 15629778
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The subunit composition of NF-kappa B complexes changes during B-cell development.
    Grumont RJ; Gerondakis S
    Cell Growth Differ; 1994 Dec; 5(12):1321-31. PubMed ID: 7696180
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Specific inhibition of RelB/p52 transcriptional activity by the C-terminal domain of p100.
    Dobrzanski P; Ryseck RP; Bravo R
    Oncogene; 1995 Mar; 10(5):1003-7. PubMed ID: 7898917
    [TBL] [Abstract][Full Text] [Related]  

  • 12. NF-kappa B2 p100 is a pro-apoptotic protein with anti-oncogenic function.
    Wang Y; Cui H; Schroering A; Ding JL; Lane WS; McGill G; Fisher DE; Ding HF
    Nat Cell Biol; 2002 Nov; 4(11):888-93. PubMed ID: 12389034
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Aberrant nuclear factor-kappaB/Rel expression and the pathogenesis of breast cancer.
    Sovak MA; Bellas RE; Kim DW; Zanieski GJ; Rogers AE; Traish AM; Sonenshein GE
    J Clin Invest; 1997 Dec; 100(12):2952-60. PubMed ID: 9399940
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Role of p52 (NF-kappaB2) in LPS tolerance in a human B cell line.
    Wedel A; Frankenberger M; Sulski G; Petersmann I; Kuprash D; Nedospasov S; Ziegler-Heitbrock HW
    Biol Chem; 1999 Oct; 380(10):1193-9. PubMed ID: 10595582
    [TBL] [Abstract][Full Text] [Related]  

  • 15. HTLV-1 Tax enhances NF-kappa B2 expression and binds to the products p52 and p100, but does not suppress the inhibitory function of p100.
    Murakami T; Hirai H; Suzuki T; Fujisawa J; Yoshida M
    Virology; 1995 Feb; 206(2):1066-74. PubMed ID: 7856081
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Novel signaling molecules implicated in tumor-associated fatty acid synthase-dependent breast cancer cell proliferation and survival: Role of exogenous dietary fatty acids, p53-p21WAF1/CIP1, ERK1/2 MAPK, p27KIP1, BRCA1, and NF-kappaB.
    Menendez JA; Mehmi I; Atlas E; Colomer R; Lupu R
    Int J Oncol; 2004 Mar; 24(3):591-608. PubMed ID: 14767544
    [TBL] [Abstract][Full Text] [Related]  

  • 17. NF- kappa B2/p100 induces Bcl-2 expression.
    Viatour P; Bentires-Alj M; Chariot A; Deregowski V; de Leval L; Merville MP; Bours V
    Leukemia; 2003 Jul; 17(7):1349-56. PubMed ID: 12835724
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Promoter of the human NF-kappa B p50/p105 gene. Regulation by NF-kappa B subunits and by c-REL.
    Cogswell PC; Scheinman RI; Baldwin AS
    J Immunol; 1993 Apr; 150(7):2794-804. PubMed ID: 8454856
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Visualization of the endogenous NF-kappa B p50 subunit in the nucleus of follicular dendritic cells in germinal centers.
    Feuillard J; Körner M; Fourcade C; Costa A; Binet JL; Debré P; Raphael M
    J Immunol; 1994 Jan; 152(1):12-21. PubMed ID: 8254185
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Rearranged NFKB2 gene in the HUT78 T-lymphoma cell line codes for a constitutively nuclear factor lacking transcriptional repressor functions.
    Zhang J; Chang CC; Lombardi L; Dalla-Favera R
    Oncogene; 1994 Jul; 9(7):1931-7. PubMed ID: 8208540
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.